Nicotine Withdrawal Drives Aversive Behaviors by Recruiting Inhibitory Interpeduncular Nucleus Inputs to the
Alexis Monical1, Daniel S Mcgehee2
1Medical Scientist Training Program, University of Chicago, Chicago, Illinois 60637.
Abstract:
Nicotine addiction remains a major cause of disease and premature death worldwide. Nicotine modulates neural pathways that underlie both rewarding and aversive behavioral effects, but persistent activation of brain reward circuitry drives nicotine consumption despite the negative consequences. When nicotine users attempt to quit, additional neural mechanisms are recruited to generate an aversive withdrawal state, which contributes to the remarkably high relapse rate among nicotine users. The interpeduncular nucleus (IPN) and its presynaptic inputs from the medial habenula are key mediators of aversive nicotine withdrawal symptoms, but the downstream neural targets mediating these effects are unknown. The aversive effects of acute exposure to high doses of nicotine require inhibitory IPN GABAergic projections to the laterodorsal tegmentum (LDTg), a key driver of reward-related dopamine signaling. Here we show that optogenetic inhibition of these IPN→LDTg projections reduces behavioral and physiological effects of nicotine withdrawal in male and female mice. Using fiber photometry, we found that nicotine withdrawal reduced reward-related signaling with decreases in both LDTg neuronal activity and nucleus accumbens dopamine release. These studies demonstrate a direct link between aversive and appetitive neural pathways that is active during nicotine withdrawal, providing novel targets for treating nicotine addiction.
More Related Videos
10:04Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices
Published on: October 29, 2012
08:47Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
CNS Depressants: Alcohol and Nicotine
